DK1675603T3 - Anvendelse af probiotiske bakterier i behandling af infektion - Google Patents

Anvendelse af probiotiske bakterier i behandling af infektion

Info

Publication number
DK1675603T3
DK1675603T3 DK04770417T DK04770417T DK1675603T3 DK 1675603 T3 DK1675603 T3 DK 1675603T3 DK 04770417 T DK04770417 T DK 04770417T DK 04770417 T DK04770417 T DK 04770417T DK 1675603 T3 DK1675603 T3 DK 1675603T3
Authority
DK
Denmark
Prior art keywords
probiotic bacteria
infection
treatment
cultures
treat
Prior art date
Application number
DK04770417T
Other languages
English (en)
Inventor
Paul Ross
Stephen Hallahan
Original Assignee
Teagasc Agric Food Dev Authori
Univ Cork
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teagasc Agric Food Dev Authori, Univ Cork filed Critical Teagasc Agric Food Dev Authori
Application granted granted Critical
Publication of DK1675603T3 publication Critical patent/DK1675603T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK04770417T 2003-10-17 2004-10-15 Anvendelse af probiotiske bakterier i behandling af infektion DK1675603T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE20030773A IE20030773A1 (en) 2003-10-17 2003-10-17 Use of probiotic bacteria in the treatment of infection
PCT/IE2004/000143 WO2005034970A1 (en) 2003-10-17 2004-10-15 Use of probiotic bacteria in the treatment of infection

Publications (1)

Publication Number Publication Date
DK1675603T3 true DK1675603T3 (da) 2009-11-30

Family

ID=34401258

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04770417T DK1675603T3 (da) 2003-10-17 2004-10-15 Anvendelse af probiotiske bakterier i behandling af infektion

Country Status (8)

Country Link
US (1) US9597362B2 (da)
EP (1) EP1675603B9 (da)
AT (1) ATE439851T1 (da)
DE (1) DE602004022689D1 (da)
DK (1) DK1675603T3 (da)
ES (1) ES2331650T3 (da)
IE (1) IE20030773A1 (da)
WO (1) WO2005034970A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2824121C (en) * 2004-02-02 2016-11-22 Zoetis Broomhill Ip Limited Method and device for treating a teat canal of an animal
WO2006076780A1 (en) * 2004-12-17 2006-07-27 Gielen Cornelis Use of non-pathogenic bacterial strains in cleaning and milking an animal
EP2081606B1 (en) 2006-11-17 2015-03-18 SCA Hygiene Products AB Sanitary article comprising a microbe-inhibiting composition
AU2006350772C1 (en) * 2006-11-17 2013-05-23 Essity Hygiene And Health Aktiebolag Hygiene tissue comprising a microbe-inhibiting composition
EP1997499A1 (en) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
US20090280099A1 (en) * 2008-05-07 2009-11-12 Bachman Stephen E Nasopharyngeal inoculate of probiotics and prebiotics for treatment of respiratory infections
UA66800U (ru) * 2011-02-08 2012-01-25 Ольга Александровна Беляева Комплексный сорбционно-пробиотический препарат линесил для лечения гнойных ран
RU2528862C1 (ru) * 2013-04-19 2014-09-20 Вячеслав Михайлович Абрамов ШТАММ Lactobacillus fermentum, ОБЛАДАЮЩИЙ ШИРОКИМ СПЕКТРОМ АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТИ И ПРОБИОТИЧЕСКИЙ КОНСОРЦИУМ ЛАКТОБАКТЕРИЙ ДЛЯ ИЗГОТОВЛЕНИЯ БАКТЕРИАЛЬНЫХ ПРЕПАРАТОВ
DE102013105666A1 (de) * 2013-06-03 2014-12-04 Hochschule Hannover Probiotische Stämme, Zusammensetzungen enthaltend probiotische Stämme sowie pharmazeutische Mittel
ES2615808T3 (es) * 2013-10-16 2017-06-08 Casen Recordati, S.L. Microorganismos y composiciones que los comprenden para su uso en el tratamiento o prevención de mastitis
EP3196644B1 (en) * 2016-01-22 2019-11-27 Mastatix, Ltd. Method for diagnosing mastitis in a lactating animal
JP2019510037A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド 抗菌ペプチド刺激性洗浄組成物
AU2017240069B2 (en) 2016-03-31 2024-03-07 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
AU2017240064B8 (en) 2016-03-31 2021-11-11 Gojo Industries, Inc. Antimicrobial peptide stimulating sanitizing composition
JP6652648B2 (ja) * 2016-09-15 2020-02-26 キリンホールディングス株式会社 乳酸菌を有効成分として含む、皮膚における特定細菌の異常増殖に起因する皮膚の状態の悪化を防止又は改善するための組成物
WO2018098152A1 (en) 2016-11-23 2018-05-31 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US11883445B2 (en) 2018-03-14 2024-01-30 Emory University Lactococcus bacteria and uses thereof
RU2709970C1 (ru) * 2019-07-05 2019-12-23 Илья Владимирович Кукес Способ лечения и профилактики острых и хронических форм мастита у животных

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
US5733568A (en) 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
IES70514B2 (en) * 1995-04-12 1996-12-11 Teagasc Agric Food Dev Authori Bacteriocins
DE69529982T2 (de) * 1995-08-07 2003-09-04 Societe Des Produits Nestle S.A., Vevey Bakteriozin
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
EP0940303B1 (en) * 1997-09-19 2008-01-02 Nissan Motor Company, Limited Apparatus for protecting crew member of automobile when collision of side portion thereof occurs
AU2001284558B2 (en) * 2000-08-08 2007-01-04 Genesis Research And Development Corporation Limited Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition
SE520670C2 (sv) * 2001-12-18 2003-08-12 Sca Hygiene Prod Ab Andningsbart absorberande alster med konformade hålrum och metod för framställning
KR100467068B1 (ko) 2002-03-06 2005-01-24 정명준 락토코쿠스 락티스 씨비티-19, 이를 이용한 항균 배양액분리 농축물의 제조 방법 및 이를 포함하는 화장료 조성물

Also Published As

Publication number Publication date
US9597362B2 (en) 2017-03-21
WO2005034970A1 (en) 2005-04-21
DE602004022689D1 (de) 2009-10-01
EP1675603A1 (en) 2006-07-05
US20080233091A1 (en) 2008-09-25
EP1675603B1 (en) 2009-08-19
EP1675603B9 (en) 2010-02-17
IE20030773A1 (en) 2005-04-20
ATE439851T1 (de) 2009-09-15
ES2331650T3 (es) 2010-01-12

Similar Documents

Publication Publication Date Title
DE602004022689D1 (de) Verwendung probiotischer bakterien zur behandlung von infektionen
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
CY1118006T1 (el) Χρηση γαλακτοβακιλλων για την αγωγη ιικων λοιμωξεων
DE502005010615D1 (de) Mittel zur behandlung von entzündlichen erkrankungen
DE60334016D1 (de) Antibakterielle mittel
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
DK1390049T3 (da) Sammensætninger til behandling af dyresygdomme og -syndromer omfattende transferfaktor
ATE481134T1 (de) Zusammensetzungen und verwendung von tyrosinkinase-hemmern zur behandlung von pathogenen infektionen
ATE461928T1 (de) Antibakterielle wirkstoffe
NO20064547L (no) Fremgangsmater for behandling av HIV infeksjon
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
EA201100413A1 (ru) Способ лечения бактериальной инфекции
ATE466585T1 (de) Präparationen grampositiver bakterien zur behandlung von krankheiten mit immunfehlregulation
TW200510449A (en) Acylated nonadepsipeptides
DE60324179D1 (de) Chinoline und stickstoffhaltige derivatedavon und deren verwendung als antibakterielle mittel
IL169701A0 (en) The use of bacterial phage-associated lysing proteins for preventing and treating bacterial infections in humans, animals and fowl
ATE484509T1 (de) Antibakterielle mittel
ATE524488T1 (de) Lysobactinamide
TW200621799A (en) Acylated nonadepsipeptides II
ATE433459T1 (de) Desoxo-nonadepsipeptide
MXPA04007491A (es) Tratamiento profilactico y terapeutico de infecciones y otras enfermedades con compuestos inmunoefectores.
ATE455789T1 (de) Substituierte nonadepsipeptide
ATE359815T1 (de) Streptococcus-phocae-vakzine
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
EP4395793A4 (en) ARTIFICIAL ENZYME-BACTERIA SYSTEM AND ITS USES